RBR-7kyk2wy
Recruiting
Phase 2
Pathophysiology of exercise intolerance in Long Covid: an integrated investigation of cardiorespiratory, muscular, metabolic and neurological mechanisms
Disciplina de Pneumologia da Universidade Federal de São Paulo0 sitesFebruary 15, 2024
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Disciplina de Pneumologia da Universidade Federal de São Paulo
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult individuals; minimum age 18 years; of both sexes; with persistent symptoms after 3 months of Covid19 infection and with right ventricular preload dysfunction (defined by a right atrial pressure at peak exercise \<7 mmHg assessed during an Invasive Cardiopulmonary Exercise Testing \- iCPET)
Exclusion Criteria
- •Patients who are unable to perform cycling exercise in order to perform an Invasive Cardiopulmonary Exercise Testing (iCPET) correctly, either due to neuromuscular limitation or due to musculoskeletal limitation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Mechanisms and Treatment of Exercise Intolerance and Persistent Fatigue in Spinal Muscular AtrophySpinal Muscular AtrophyNCT05518773Columbia University34
Recruiting
Not Applicable
Clinical study on exercise intolerance and multifaceted frailty in patients receiving hemodialysis and their clinical outcomes: a prospective cohort studyEnd-stage kidney diseaseJPRN-UMIN000045680Department of rehabilitation, Kisen Hospital300
Not yet recruiting
Not Applicable
Improvement of exercise tolerance by a long-term assisting use of the short acting beta 2 agonist (procaterol) for pulmonary rehabilitation in patients with COPD.Chronic Obstructive Pulmonary DiseaseCOPDJPRN-UMIN000009577Department of Occupational Health, Tohoku University School of Medicine,120
Not yet recruiting
Not Applicable
Exertional breathlessness in pulmonary arterial hypertensioACTRN12622000494730niversity of Auckland15
Completed
Phase 4
Exertional breathlessness in pulmonary arterial hypertensioACTRN12622000505707niversity of Auckland9